September 21, 2022 Experience Nayax direct listing The shares are listed on the Nasdaq Global Select Market
September 19, 2022 Experience Interra Acquisition HK$1 billion IPO We advised the SPAC on its IPO and HKEX listing
September 1, 2022 Experience Biocytogen HK$549 million IPO We advised Biocytogen on its IPO and HKEX listing
July 12, 2022 Experience Tuya global offering and dual primary listing on the Hong Kong Stock Exchange We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX
May 18, 2022 Experience Financials Acquisition £150 million IPO The shares are listed on the London Stock Exchange
May 17, 2022 Experience Beike’s dual primary listing on the Hong Kong Stock Exchange This is the first dual primary listing by way of introduction with WVR structure on the HKEX
May 13, 2022 Experience Investcorp India Acquisition $258.8 million IPO The SPAC offering consists of 25,875,000 units
May 10, 2022 Experience Bausch + Lomb $630 million IPO We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
May 5, 2022 Experience RA Special Acquisition $230 million IPO The SPAC IPO shares are listed on Euronext Amsterdam
May 3, 2022 Experience HilleVax $200 million IPO The shares are listed on the Nasdaq Global Select Market